Klox Technologies Inc. is a biomedical innovator founded by renown entrepreneur and co-founder of BioChem Pharma, Dr. Francesco Bellini. Klox is advancing the development and commercialization of its proprietary Fluorescence Biomodulation technology platform.
- Klox focuses on the development, innovation and delivery of launch-ready technology and products.
- To commercialize the Fluorescence Biomodulation technology, Klox relies on investment capital and long-term business partners with expertise in our therapeutic categories.
- Please contact Business Development for any partnering inquiries.